Alcon

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Alcon and other ETFs, options, and stocks.

About ALC

Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through the Surgical and Vision Care segments. 

CEO
David J. Endicott
CEODavid J. Endicott
Employees
25,599
Employees25,599
Headquarters
Geneva, Geneve (Geneva)
HeadquartersGeneva, Geneve (Geneva)
Founded
1945
Founded1945
Employees
25,599
Employees25,599

ALC Key Statistics

Market cap
40.40B
Market cap40.40B
Price-Earnings ratio
37.83
Price-Earnings ratio37.83
Dividend yield
0.39%
Dividend yield0.39%
Average volume
3.25M
Average volume3.25M
High today
$82.83
High today$82.83
Low today
$80.76
Low today$80.76
Open price
$82.70
Open price$82.70
Volume
1.89M
Volume1.89M
52 Week high
$101.10
52 Week high$101.10
52 Week low
$78.11
52 Week low$78.11

ALC News

TipRanks 4d
Alcon’s Resilient Financial Strategy and Market Position Earns ‘Buy’ Rating Despite Revenue Miss

Needham analyst David Saxon reiterated a Buy rating on Alcon on August 20 and set a price target of $107.00. Elevate Your Investing Strategy: Take advantage of...

Seeking Alpha 4d
Alcon downgraded at J.P. Morgan on Q2 results

Healthcare Alcon downgraded at J.P. Morgan on Q2 results Aug. 21, 2025 10:42 AM ET Alcon Inc. (ALC) Stock By: Dulan Lokuwithana, SA News Editor 5 Share Save (...

Alcon downgraded at J.P. Morgan on Q2 results
Benzinga 4d
These Analysts Slash Their Forecasts On Alcon After Q2 Earnings

Alcon Inc ALC posted better-than-expected earnings for the second quarter and cut its 2025 outlook late on Tuesday, citing increased tariff impact. The company...

These Analysts Slash Their Forecasts On Alcon After Q2 Earnings

Analyst ratings

74%

of 31 ratings
Buy
74.2%
Hold
25.8%
Sell
0%

More ALC News

TipRanks 4d
Alcon price target lowered to $80 from $84 at Morgan Stanley

Morgan Stanley analyst Patrick Wood lowered the firm’s price target on Alcon (ALC) to $80 from $84 and keeps an Equal Weight rating on the shares after updating...

Seeking Alpha 5d
Alcon updates 2025 revenue outlook to $10.3B–$10.4B while advancing strategic acquisitions and new product launches

Earnings Call Insights Alcon updates 2025 revenue outlook to $10.3B–$10.4B while advancing strategic acquisitions and new product launches Aug. 20, 2025 9:11 PM...

Alcon updates 2025 revenue outlook to $10.3B–$10.4B while advancing strategic acquisitions and new product launches
Benzinga 5d
Alcon Cites Tariffs And Soft Market In Lowered Sales Outlook, Shares Fall

Swiss-American eye care firm Alcon Inc ALC stock slumped on Wednesday after the company cut its 2025 outlook late on Tuesday, citing increased tariff impact. T...

Alcon Cites Tariffs And Soft Market In Lowered Sales Outlook, Shares Fall
TipRanks 5d
Alcon’s Strong EPS Performance and Promising Outlook Justify Buy Rating Despite Revenue and EBIT Challenges

Julien Ouaddour, an analyst from Bank of America Securities, maintained the Buy rating on Alcon. The associated price target remains the same with CHF89.00. Ele...

TipRanks 6d
Alcon’s Strategic Moves: Q2 2025 Results and STAAR Acquisition

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

TipRanks 6d
Alcon reports Q2 EPS 76c, consensus 72c

Reports Q2 revenue $2.58B, consensus $2.64B. “Alcon (ALC) is exiting the second quarter with solid momentum, despite a relatively soft surgical market in the fi...

People also own

Based on the portfolios of people who own ALC. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.